For over 25 years, the world of healthcare has experienced phenomenal growth through the input of one scholar and entrepreneur, Jim Tananbaum. The Forbes-listed individual has been at the forefront of pushing for innovative and strategic growth of healthcare in the fields of
- Genome sequencing
In his push endeavors, Jim Tananbaum founded Foresite Capital, which is an equity venture firm dedicated to only healthcare-dedicated concepts and products. He has been according to deserving healthcare start-ups with necessary financial, strategic and operational assistance. Through such providences, some companies and firms, over 77 of them, have risen to operate profitably yet impacting the world positively. Some of the companies include,
- 10x Genomics,
- Intarcia Therapeutics,
- Aerie Pharmaceuticals
- and Aimmune Therapeutics.
In a recent interview that was conducted by INC42, Jim Tananbaum revealed some insightful methods that he employs to stay afloat of the dynamic and risky entrepreneurial world of bio-pharmaceuticals. He claimed that his biggest asset had been the time he spends peeking the minds of top players in his field of specialty. He attests that it is difficult to keep abreast of the dynamic and innovative pharmaceutical industry without ample knowledge and connections.
To Jim, investment takes more than just the mobilization of capital. Success cannot be bought or given. Individuals must have sufficient mastery of the operational needs of the business as well as a passion for doing things the right way. He attributed academic prowess and commitment to sustained efficiency in leadership in the science of preventing diseases. He revealed that he spends time reading and researching; that he always yearns to learn more.
He also acknowledged the power o persistence and resilience in amassing the wealth of expertise, reputation, and fiscal assets that he is worth today. To Jim Tananbaum, the only bad job is one that isn’t well done. He asserts that all jobs in the world are attractive to those with the passion for doing them and those put in coherent teams. A team without synergy fails to meet its objectives and subjects its members to frustration.
Jim Tananbaum is an avid entrepreneur and scholar. He is the co-founder of two of the world’s most innovative health-care firms in the world, GelTex Pharmaceuticals NASDAQ and, Theravance Biopharma, Inc. The two only, are worth 3.2 billion dollars. The healthcare sensation is also the founder and CEO of Foresite Capital.
Follow him on Twitter